Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 337

1.

Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study.

Weber-Schoendorfer C, Schaefer C.

Mult Scler. 2009 Sep;15(9):1037-42. doi: 10.1177/1352458509106543.

PMID:
19692433
2.

The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort.

Boskovic R, Wide R, Wolpin J, Bauer DJ, Koren G.

Neurology. 2005 Sep 27;65(6):807-11. Erratum in: Neurology. 2005 Dec 27;65(12):1992.

PMID:
16186517
3.

Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.

Giannini M, Portaccio E, Ghezzi A, Hakiki B, Pastò L, Razzolini L, Piscolla E, De Giglio L, Pozzilli C, Paolicelli D, Trojano M, Marrosu MG, Patti F, La Mantia L, Mancardi G, Solaro C, Totaro R, Tola MR, De Luca G, Lugaresi A, Moiola L, Martinelli V, Comi G, Amato MP.

BMC Neurol. 2012 Oct 22;12:124. doi: 10.1186/1471-2377-12-124.

4.

Epidemiological characteristics of pregnancy, delivery, and birth outcome in women with multiple sclerosis in Argentina (EMEMAR study).

Fernández Liguori N, Klajn D, Acion L, Cáceres F, Calle A, Carrá A, Cristiano E, Deri N, Garcea O, Jaureguiberry A, Onaha P, Patrucco L, Riccio P, Rotta Escalante R, Saladino Ml, Sinay V, Tarulla A, Villa A.

Mult Scler. 2009 May;15(5):555-62. doi: 10.1177/1352458509102366. Epub 2009 Mar 19.

PMID:
19299437
5.

Glatiramer acetate versus interferon beta-1a for subcutaneous administration: comparison of outcomes among multiple sclerosis patients.

Castelli-Haley J, Oleen-Burkey M, Lage MJ, Johnson KP.

Adv Ther. 2008 Jul;25(7):658-73. doi: 10.1007/s12325-008-0077-z. Erratum in: Adv Ther. 2008 Aug;25(8):830. Oleen-Burkey, Merry-Kay A [corrected to Oleen-Burkey, MerriKay].

PMID:
18641926
6.

Immunogenicity and tolerability of an investigational formulation of interferon-beta1a: 24- and 48-week interim analyses of a 2-year, single-arm, historically controlled, phase IIIb study in adults with multiple sclerosis.

Giovannoni G, Barbarash O, Casset-Semanaz F, Jaber A, King J, Metz L, Pardo G, Simsarian J, Sørensen PS, Stubinski B; RNF Study Group.

Clin Ther. 2007 Jun;29(6):1128-45.

PMID:
17692727
7.

Glatiramer acetate in treatment-naïve and prior interferon-beta-1b-treated multiple sclerosis patients.

Zwibel HL; Copolymer-1 Treatment Study Principal Investigators.

Acta Neurol Scand. 2006 Jun;113(6):378-86.

PMID:
16674604
8.

The safety of cetirizine during pregnancy. A prospective observational cohort study.

Weber-Schoendorfer C, Schaefer C.

Reprod Toxicol. 2008 Sep;26(1):19-23. doi: 10.1016/j.reprotox.2008.05.053. Epub 2008 May 13.

PMID:
18571373
9.

Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.

McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O, Levinson A, Zipursky RB, Einarson A.

J Clin Psychiatry. 2005 Apr;66(4):444-9; quiz 546.

PMID:
15816786
10.

The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.

Weber-Schoendorfer C, Hannemann D, Meister R, Eléfant E, Cuppers-Maarschalkerweerd B, Arnon J, Vial T, Rodriguez-Pinilla E, Clementi M, Robert-Gnansia E, De Santis M, Malm H, Dolivo A, Schaefer C.

Reprod Toxicol. 2008 Sep;26(1):24-30. doi: 10.1016/j.reprotox.2008.05.065. Epub 2008 Jun 7.

PMID:
18585452
11.

Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis.

Sandberg-Wollheim M, Frank D, Goodwin TM, Giesser B, Lopez-Bresnahan M, Stam-Moraga M, Chang P, Francis GS.

Neurology. 2005 Sep 27;65(6):802-6. Epub 2005 Aug 10. Review.

PMID:
16093457
12.

Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis.

Amato MP, Portaccio E, Ghezzi A, Hakiki B, Zipoli V, Martinelli V, Moiola L, Patti F, La Mantia L, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A, Di Tommaso V, Paolicelli D, Marrosu MG, Comi G, Pellegrini F, Trojano M; MS Study Group of the Italian Neurological Society.

Neurology. 2010 Nov 16;75(20):1794-802. doi: 10.1212/WNL.0b013e3181fd62bb.

PMID:
21079181
13.

Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study.

Diav-Citrin O, Shechtman S, Ornoy S, Arnon J, Schaefer C, Garbis H, Clementi M, Ornoy A.

J Clin Psychiatry. 2005 Mar;66(3):317-22.

PMID:
15766297
14.

Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study.

Bar-Oz B, Moretti ME, Bishai R, Mareels G, Van Tittelboom T, Verspeelt J, Koren G.

Am J Obstet Gynecol. 2000 Sep;183(3):617-20.

PMID:
10992182
15.

Fetal outcome after technetium scintigraphy in early pregnancy.

Schaefer C, Meister R, Wentzeck R, Weber-Schoendorfer C.

Reprod Toxicol. 2009 Sep;28(2):161-6. doi: 10.1016/j.reprotox.2009.05.001. Epub 2009 May 13.

PMID:
19442716
16.

Combination therapy with interferon-beta and glatiramer acetate in multiple sclerosis.

Ytterberg C, Johansson S, Andersson M, Olsson D, Link H, Holmqvist LW, von Koch L.

Acta Neurol Scand. 2007 Aug;116(2):96-9.

PMID:
17661794
17.

Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study.

Schaefer C, Hannemann D, Meister R, Eléfant E, Paulus W, Vial T, Reuvers M, Robert-Gnansia E, Arnon J, De Santis M, Clementi M, Rodriguez-Pinilla E, Dolivo A, Merlob P.

Thromb Haemost. 2006 Jun;95(6):949-57.

PMID:
16732373
18.

Post-marketing surveillance system for drugs in pregnancy--15 years experience of ENTIS.

Schaefer C, Hannemann D, Meister R.

Reprod Toxicol. 2005 Sep-Oct;20(3):331-43. Review.

PMID:
15978773
19.

An association between autoreactive antibodies and anti-interferon-beta antibodies in multiple sclerosis.

Garg N, Weinstock-Guttman B, Bhasi K, Locke J, Ramanathan M.

Mult Scler. 2007 Aug;13(7):895-9. Epub 2007 Apr 27.

PMID:
17468449
20.

Interferon-beta1b for the treatment of multiple sclerosis.

Lam S, Wang S, Gottesman M.

Expert Opin Drug Metab Toxicol. 2008 Aug;4(8):1111-7. doi: 10.1517/17425255.4.8.1111 . Review.

PMID:
18680445

Supplemental Content

Support Center